Sirolimus (Rapamune) for the treatment of anti-Hu associated paraneoplastic neurological syndromes

Trial Profile

Sirolimus (Rapamune) for the treatment of anti-Hu associated paraneoplastic neurological syndromes

Recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Nov 2015

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Encephalomyelitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Nov 2015 New source identified and integrated (European Clinical Trials Database : EudraCT 2008-000793-20)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top